Page last updated: 2024-08-25

zoledronic acid and Back Pain

zoledronic acid has been researched along with Back Pain in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Dedeyne, L; Dejaeger, M; Dupont, J; Gielen, E; Laurent, MR; Luyten, FP1
Gan, F; Ge, Y; Liu, B; Yu, H1
Han, K; Hu, H; Shen, Z; Sun, Y; Tang, L; Wang, Y; Wu, C; Yao, Y; Zhang, J1
Bokhari, SW; Jones, FM1
Anderson, KC; Bianchi, G; Richardson, PG1
Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M1
Black, D; Boonen, S; Cauley, JA; Cummings, SR; Hadji, P; Man, Z; Mesenbrink, P; Palermo, L; Reid, IR1
Andrada, E; Cánovas, V; Carrato, A; Guillén-Ponce, C; Guirado-Risueño, M; Martín Hidalgo, A; Molina, MA; Molina, MJ; Molina-Garrido, MJ; Mora, A; Pastor, E1

Trials

2 trial(s) available for zoledronic acid and Back Pain

ArticleYear
Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2018, Volume: 31, Issue:5

    Topics: Aged; Aged, 80 and over; Back Pain; Bone Density Conservation Agents; Combined Modality Therapy; Female; Follow-Up Studies; Fractures, Compression; Humans; Kyphoplasty; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Retrospective Studies; Spinal Fractures; Treatment Outcome; Zoledronic Acid

2018
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:5

    Topics: Back Pain; Bed Rest; Bone Density Conservation Agents; Diphosphonates; Disabled Persons; Drug Administration Schedule; Female; Humans; Imidazoles; Multivariate Analysis; Prevalence; Probability; Risk Factors; Spinal Fractures; Zoledronic Acid

2011

Other Studies

6 other study(ies) available for zoledronic acid and Back Pain

ArticleYear
Vertebral fractures after denosumab cessation.
    Cleveland Clinic journal of medicine, 2020, Volume: 87, Issue:6

    Topics: Back Pain; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Diagnosis, Differential; Drug Substitution; Female; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Risk Adjustment; Secondary Prevention; Spinal Fractures; Thoracic Vertebrae; Withholding Treatment; Zoledronic Acid

2020
Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer.
    Journal of vascular and interventional radiology : JVIR, 2013, Volume: 24, Issue:12

    Topics: Adult; Aged; Back Pain; Bone Density Conservation Agents; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Karnofsky Performance Status; Middle Aged; Osteolysis; Pain Measurement; Quality of Life; Retrospective Studies; Spinal Neoplasms; Surveys and Questionnaires; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vertebroplasty; Zoledronic Acid

2013
Hyperammonemic encephalopathy in multiple myeloma.
    Annals of hematology, 2014, Volume: 93, Issue:8

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Boronic Acids; Bortezomib; Brain; Brain Edema; Coma; Cyclophosphamide; Dexamethasone; Diphosphonates; Fatal Outcome; Humans; Hyperammonemia; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteolysis; Pyrazines; Tomography, X-Ray Computed; Zoledronic Acid

2014
Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jul-10, Volume: 32, Issue:20

    Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy; Bone Density Conservation Agents; Bone Marrow; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Fatigue; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Immunoglobulin G; Immunoglobulin lambda-Chains; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Pyrazines; Referral and Consultation; Thalidomide; Translocation, Genetic; Transplantation, Autologous; Zoledronic Acid

2014
Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Spine, 2009, Aug-01, Volume: 34, Issue:17

    Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Histamine; Humans; Hypotension; Imidazoles; Male; Mast Cells; Mastocytosis, Systemic; Osteoporosis; Postoperative Complications; Prednisolone; Pressure; Proto-Oncogene Proteins c-kit; Spinal Fractures; Spine; Treatment Outcome; Vertebroplasty; Zoledronic Acid

2009
Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:4

    Topics: Aged; Anemia; Back Pain; Bone Density Conservation Agents; Bone Neoplasms; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypertension; Imidazoles; Immunologic Factors; Interferon-alpha; Magnetic Resonance Imaging; Mastocytosis, Systemic; Osteolysis; Osteoporosis; Radionuclide Imaging; Zoledronic Acid

2008